NCT01906333

Brief Summary

There is increasing evidence that skeletal muscle lipid content (IntraMyoCellular Lipid, IMCL) markedly increases the risk of metabolic complications, including insulin resistance and cardiovascular events. The investigator hypothesizes that skeletal muscle is passively taking up FFAs when the availability is high, thereby leading to an increased storage. To test this hypothesis, the investigator wants to manipulate FFA levels, by means of exercise, and monitor intramuscular lipid content. Therefore the objective is to examine the effect of an exercise-induced elevation of FFA on skeletal muscle lipid content in healthy lean men. To this end, skeletal muscle lipid content will be investigated at baseline and after an exercise protocol and again after a four-hour recovery period from exercise, once in a condition with high FFA concentration, once with low FFA concentration. To achieve high- versus low FFA concentrations, an exercise protocol was chosen and participants had to perform this protocol once with a glucose supplementation and once without. Skeletal muscle lipid content will be determined before, directly after exercise and 4 h post exercise (from muscle biopsies) with or without glucose supplementation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable diabetes

Timeline
Completed

Started May 2013

Shorter than P25 for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 16, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 24, 2013

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

May 28, 2015

Status Verified

May 1, 2015

Enrollment Period

3 months

First QC Date

July 16, 2013

Last Update Submit

May 27, 2015

Conditions

Keywords

ExerciseEctopic fat accumulation

Outcome Measures

Primary Outcomes (1)

  • Change in IntraMyoCellularLipid (IMCL)content

    A muscle biopsy will be withdrawn before, after 2 hours of exercise and again 4 hours post-exercise for later analysis of IMCL.

    Baseline, directly postexercise and 4 hours post-exercise

Secondary Outcomes (1)

  • Change in substrate metabolism

    Measured several time points during the test day

Study Arms (2)

Exercise & Glucose

EXPERIMENTAL

2 hour exercise while getting glucose-supplementation

Other: ExerciseOther: Glucose

Exercise & Fasted

EXPERIMENTAL

2 hour exercise while staying fasted

Other: ExerciseOther: Fasted

Interventions

Exercise & FastedExercise & Glucose
GlucoseOTHER
Exercise & Glucose
FastedOTHER
Exercise & Fasted

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male sex
  • Age 18-30 years
  • Lean, BMI 18-25 kg/m2
  • Healthy
  • Stable dietary habits
  • No medication use

You may not qualify if:

  • Female sex
  • Engagement in programmed exercise \> 2 hours total per week
  • Cardiac problems, such as angina pectoris, cardiac infarction and arrhythmias
  • First degree relatives with type 2 diabetes mellitus
  • Any medical condition requiring treatment and/or medication use
  • Unstable body weight (weight gain or loss \> 3 kg in the past three months)
  • Participation in other biomedical study within 1 month prior to the screening visit
  • Subjetcs, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician is informed, cannot participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Human Biology, Maastricht University Medical Center (MUMC)

Maastricht, Netherlands

Location

MeSH Terms

Conditions

Diabetes MellitusMotor Activity

Interventions

ExerciseGlucose

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHexosesMonosaccharidesSugarsCarbohydrates

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student

Study Record Dates

First Submitted

July 16, 2013

First Posted

July 24, 2013

Study Start

May 1, 2013

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

May 28, 2015

Record last verified: 2015-05

Locations